Akebia Therapeutics (AKBA) Secures $50M Investment at $14/Sh from Vifor Pharma for Exclusive Distribution of Vadadustat to Fresenius Medical Care North America for Dialysis Facilities
Tweet Send to a Friend
Akebia Therapeutics, Inc. (NASDAQ: AKBA) and ​Vifor Pharma Group today announced they have entered into an exclusive license agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
